Literature DB >> 7858702

Determination of quinidine, dihydroquinidine, (3S)-3-hydroxyquinidine and quinidine N-oxide in plasma and urine by high-performance liquid chromatography.

F Nielsen1, K K Nielsen, K Brøsen.   

Abstract

A specific and sensitive method for the quantitation of quinidine, (3S)-3-hydroxyquinidine, quinidine N-oxide, and dihydroquinidine in plasma and urine has been developed. The method is based on a single-step, liquid-liquid extraction procedure, followed by isocratic reversed-phase high-performance liquid chromatography, with fluorescence detection. After extraction from 250 microliters plasma and 100 microliters urine, the limit of determination is 10 nM and 25 nM, respectively. For the use as standards, commercially available quinidine was purified from dihydroquinidine; quinidine N-oxide was synthesized.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7858702     DOI: 10.1016/0378-4347(94)00259-2

Source DB:  PubMed          Journal:  J Chromatogr B Biomed Appl        ISSN: 1572-6495


  7 in total

1.  Effect of diclofenac, disulfiram, itraconazole, grapefruit juice and erythromycin on the pharmacokinetics of quinidine.

Authors:  P Damkier; L L Hansen; K Brosen
Journal:  Br J Clin Pharmacol       Date:  1999-12       Impact factor: 4.335

2.  Systemic uptake of miconazole during vaginal suppository use and effect on CYP1A2 and CYP3A4 associated enzyme activities in women.

Authors:  Mia Birkhøj Kjærstad; Flemming Nielsen; Lene Nøhr-Jensen; Stine Zwisler; Kim Brøsen; Helle Raun Andersen
Journal:  Eur J Clin Pharmacol       Date:  2010-10-06       Impact factor: 2.953

3.  The impact of CYP2C8 polymorphism and grapefruit juice on the pharmacokinetics of repaglinide.

Authors:  Tanja Busk Bidstrup; Per Damkier; Anette Kristensen Olsen; Marianne Ekblom; Anders Karlsson; Kim Brøsen
Journal:  Br J Clin Pharmacol       Date:  2006-01       Impact factor: 4.335

4.  Impact of quinidine on plasma and cerebrospinal fluid concentrations of codeine and morphine after codeine intake.

Authors:  S H Sindrup; U Hofmann; J Asmussen; G Mikus; K Brøsen; F Nielsen; S H Ingwersen; C Broen Christensen
Journal:  Eur J Clin Pharmacol       Date:  1996       Impact factor: 2.953

5.  Quinidine does not affect the renal clearance of moxonidine.

Authors:  Stephen D Wise; Clark Chan; Hans G Schaefer; Minxia M He; Isabelle J Pouliquen; Malcolm I Mitchell
Journal:  Br J Clin Pharmacol       Date:  2002-09       Impact factor: 4.335

6.  Lack of relationship between quinidine pharmacokinetics and the sparteine oxidation polymorphism.

Authors:  F Nielsen; J U Rosholm; K Brøsen
Journal:  Eur J Clin Pharmacol       Date:  1995       Impact factor: 2.953

7.  Rifampicin seems to act as both an inducer and an inhibitor of the metabolism of repaglinide.

Authors:  Tanja Busk Bidstrup; Nicolaj Stilling; Per Damkier; Birgitte Scharling; Mikael Søndergård Thomsen; Kim Brøsen
Journal:  Eur J Clin Pharmacol       Date:  2004-03-19       Impact factor: 2.953

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.